Wed Sep 25 04:18:49 UTC 2024: ## Jin Medical International Outperforms Nutriband in Investment Analysis

**MarketBeat News** has compared two small-cap medical companies, **Jin Medical International (ZJYL)** and **Nutriband (NTRB)**, across various investment factors.

Jin Medical International emerges as the stronger investment, surpassing Nutriband in six out of nine key areas, including analyst recommendations, earnings, dividends, profitability, valuation, and risk.

**Key Findings:**

* **Volatility:** Jin Medical International exhibits significantly higher volatility than the S&P 500 with a beta of 15.77, while Nutriband’s beta of 1.08 indicates a more moderate 8% volatility.
* **Financial Performance:** Jin Medical International boasts stronger revenue, earnings per share, and valuation metrics compared to Nutriband.
* **Institutional Ownership:** Nutriband has a higher percentage of shares owned by institutional investors (19.7%) compared to Jin Medical International, suggesting a higher level of confidence from large money managers.
* **Insiders:** Nutriband also has a higher insider ownership (43.2%), which could indicate a positive outlook from company executives.

**Company Profiles:**

* **Jin Medical International:** A Chinese company specializing in wheelchair and other living aids for individuals with disabilities, offering products such as oxygen concentrators and bathing machines.
* **Nutriband:** An American company focusing on the development of transdermal pharmaceutical products, with a lead product being an abuse deterrent fentanyl transdermal system for pain management.

**Conclusion:**

Based on the analysis conducted by MarketBeat, Jin Medical International appears to be a more attractive investment opportunity than Nutriband, demonstrating stronger financial performance and a better overall investment profile. However, investors should conduct thorough due diligence and consider their individual investment goals before making any decisions.

Read More